Russia's Sputnik Light COVID-19 vaccine approved for use in Palestine

Palestine

Published: 2021-05-31 15:48

Last Updated: 2021-06-12 11:21


Russia's Sputnik Light COVID-19 vaccine approved for use in Palestine
Russia's Sputnik Light COVID-19 vaccine approved for use in Palestine

Monday, Russia’s single-dose Sputnik Light COVID-19 vaccine has been approved for use in Palestine, according to Russia’s RDIF sovereign wealth fund.

Notably, the RDIF fund is marketing the Russian vaccine abroad.

May 6, the Russian government officially approved its fourth coronavirus vaccine, Sputnik Light, according to statements from the RDIF.

Only one dose of the Sputnik Light vaccine is required, in comparison to the two-dose Sputnik V vaccine.

Researchers and experts claim it has an efficacy rate of up to 79.4 percent, and hope it will speed up immunization against COVID-19.